MyAverix Finance
NS · Healthcare
Unjha Formulations Ltd (531762)
Pharmaceuticals & Biotechnology
Unjha Formulations Ltd (531762) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $89.60M, P/E ratio is 12.73, net margin is 3.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 531762
Unjha Formulations Ltd (531762) — FAQ
What is Unjha Formulations Ltd's market cap?
Unjha Formulations Ltd (531762) has a reported market cap of $89.60M (data as of 2026-07-10).
What is 531762's P/E ratio?
The price-to-earnings (P/E) ratio for Unjha Formulations Ltd (531762) is 12.73 (data as of 2026-07-10).
Does Unjha Formulations Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Unjha Formulations Ltd (531762). Check the MyAverix Finance app for the latest dividend data.
What sector is Unjha Formulations Ltd in?
Unjha Formulations Ltd (531762) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 531762 listed on?
531762 is listed on NS.
What is Unjha Formulations Ltd's net margin?
Unjha Formulations Ltd (531762) reports a net margin of 3.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.